Adaptation to a Multiplex Bead Assay and Seroprevalence to Rift Valley Fever N Protein: Nampula Province, Mozambique, 2013-2014.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
24 08 2022
Historique:
pubmed: 28 7 2022
medline: 27 8 2022
entrez: 27 7 2022
Statut: ppublish

Résumé

Rift Valley fever virus (RVFV) is endemic in sub-Saharan Africa (SSA), with outbreaks reported in the Arabian Peninsula and throughout SSA. The natural reservoir for RVFV are ruminants, with livestock populations exceeding 50% exposure rates in some areas of SSA. Transmission to humans can occur through exposure to infected livestock products or multiple species of mosquito vectors. In 2013 and 2014, cross-sectional surveys occurred in two districts of Nacala-a-Velha and Mecubúri in northern Mozambique, and participants provided blood samples for later serological assays. IgG against the N protein of RVFV was detected through multiplex bead assay (MBA). Of the 2,278 persons enrolled between the two surveys and study sites, 181 (7.9%, 95% confidence interval (CI): 6.9%-9.1%) were found to be IgG seropositive with increasing seroprevalence with older age and significantly higher seroprevalence in Nacala-a-Velha (10.5%, 8.8%-12.5%) versus Mecubúri (5.7%, 4.5%-7.1%). Seroprevalence estimates were not significantly different between the 2013 and 2014 surveys. Significant spatial clustering of IgG positive persons were consistent among surveys and within the two districts, pointing toward the consistency of serology data for making population-level assumptions regarding RVFV seroprevalence. A subset of persons (

Identifiants

pubmed: 35894603
doi: 10.1128/jvi.00672-22
pmc: PMC9400480
doi:

Substances chimiques

Antibodies, Viral 0
Immunoglobulin G 0
Nucleocapsid Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0067222

Références

PLoS Negl Trop Dis. 2019 Mar 20;13(3):e0007258
pubmed: 30893298
Am J Trop Med Hyg. 2019 Mar;100(3):659-671
pubmed: 30675833
J Clin Microbiol. 2018 May 25;56(6):
pubmed: 29563201
Infect Ecol Epidemiol. 2015 Jul 31;5:28024
pubmed: 26234531
Am J Trop Med Hyg. 2015 Dec;93(6):1364-1370
pubmed: 26458775
Am J Trop Med Hyg. 2018 Mar;98(3):872-874
pubmed: 29363462
J Virol. 2008 Nov;82(22):11152-66
pubmed: 18786992
Rev Sci Tech. 1996 Sep;15(3):937-46
pubmed: 9025143
PLoS One. 2018 Feb 7;13(2):e0192110
pubmed: 29415070
Am J Trop Med Hyg. 2014 Apr;90(4):653-60
pubmed: 24591430
J Virol. 2011 Jul;85(13):6098-105
pubmed: 21450816
Philos Trans R Soc Lond B Biol Sci. 2017 Jul 19;372(1725):
pubmed: 28584173
Front Immunol. 2021 Mar 02;12:617951
pubmed: 33737926
Emerg Infect Dis. 1998 Apr-Jun;4(2):289-93
pubmed: 9621201
J Virol Methods. 2019 Jul;269:70-76
pubmed: 30974177
J Clin Microbiol. 2019 Sep 24;57(10):
pubmed: 31366690
Viruses. 2011 May;3(5):493-519
pubmed: 21666766
J Immunol Methods. 2006 Feb 20;309(1-2):200-4
pubmed: 16406059
Med Vet Entomol. 2018 Jun;32(2):259-262
pubmed: 29383746
Vet Microbiol. 2007 Mar 31;121(1-2):29-38
pubmed: 17187944
Trop Med Int Health. 2014 Dec;19(12):1420-9
pubmed: 25252137
PLoS Negl Trop Dis. 2018 Oct 30;12(10):e0006858
pubmed: 30376568
Adv Exp Med Biol. 2018;1062:11-18
pubmed: 29845522
J Virol Methods. 2007 Mar;140(1-2):106-14
pubmed: 17174410
Nat Rev Immunol. 2020 Apr;20(4):229-238
pubmed: 31836872
Virol J. 2016 Jun 08;13:96
pubmed: 27278404
Lancet Planet Health. 2020 Sep;4(9):e416-e423
pubmed: 32918887
PLoS Negl Trop Dis. 2013;7(2):e2065
pubmed: 23469300
Emerg Infect Dis. 2018 Jun;24(6):995-1001
pubmed: 29774861
Front Vet Sci. 2015 Nov 25;2:63
pubmed: 26664990
Clin Chem. 1993 Apr;39(4):561-77
pubmed: 8472349
PLoS Negl Trop Dis. 2011 Aug;5(8):e1265
pubmed: 21858236
Epidemiol Infect. 1987 Oct;99(2):517-22
pubmed: 3678406
Methods Mol Biol. 2020;2052:61-85
pubmed: 31452157
mSphere. 2021 Oct 27;6(5):e0055621
pubmed: 34494884
Infect Ecol Epidemiol. 2016 Jul 04;6:31343
pubmed: 27388698
Bull World Health Organ. 2016 Nov 01;94(11):817-825A
pubmed: 27821884
J Am Vet Med Assoc. 2009 Apr 1;234(7):883-93
pubmed: 19335238
Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):938-943
pubmed: 28096420
PLoS One. 2013 Jun 28;8(6):e66626
pubmed: 23840512
Malar J. 2015 Nov 04;14:436
pubmed: 26537125
Emerg Infect Dis. 2013 Jul;19(7):1177-9
pubmed: 23764189
Vector Borne Zoonotic Dis. 2018 Aug;18(8):445-449
pubmed: 29733254
PLoS Negl Trop Dis. 2018 Feb 14;12(2):e0006278
pubmed: 29444078
Res Vet Sci. 2013 Oct;95(2):725-30
pubmed: 23664015
PLoS Negl Trop Dis. 2020 Feb 21;14(2):e0007979
pubmed: 32084127
Emerg Infect Dis. 2016 Dec;22(12):2165-2167
pubmed: 27869589
PLoS Negl Trop Dis. 2017 May 19;11(5):e0005616
pubmed: 28542223

Auteurs

Eric Rogier (E)

Division of Parasitic Diseases and Malaria, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.

Mateusz Plucinski (M)

Division of Parasitic Diseases and Malaria, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.
US President's Malaria Initiative, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.

Baltazar Candrinho (B)

National Malaria Control Program, Ministry of Health, Maputo, Mozambique, Africa.

Delynn M Moss (DM)

Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.

Aridth Gibbons (A)

Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.

James Colborn (J)

Clinton Health Access Initiative, Boston, Massachusetts, USA.

Jeffrey Higgins (J)

Office of Innovation and Analytics, Centers for Disease Control and Preventiongrid.416738.f/Agency for Toxic Substances and Disease Registry, Atlanta, Georgia, USA.

Geraldo Chambe (G)

Mozambique Field Epidemiology and Laboratory Training Program, Maputo, Mozambique, Africa.

Joao Muchanga (J)

Mozambique Field Epidemiology and Laboratory Training Program, Maputo, Mozambique, Africa.

Olinda Muguande (O)

National Malaria Control Program, Ministry of Health, Maputo, Mozambique, Africa.

Graca Matsinhe (G)

National Malaria Control Program, Ministry of Health, Maputo, Mozambique, Africa.

Guidion Mathe (G)

National Malaria Control Program, Ministry of Health, Maputo, Mozambique, Africa.

Timothy Doyle (T)

Field Epidemiology and Laboratory Training Program, Centers for Disease Control and Preventiongrid.416738.f, Maputo, Mozambique, Africa.

Rose Zulliger (R)

Division of Parasitic Diseases and Malaria, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.
US President's Malaria Initiative, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.

Abu Saifodine (A)

US President's Malaria Initiative, United States Agency for International Developmentgrid.420285.9, Maputo, Mozambique, Africa.

Joel M Montgomery (JM)

Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.

John D Klena (JD)

Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.

Jeffrey W Priest (JW)

Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Preventiongrid.416738.f, Atlanta, Georgia, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH